• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过交叉免疫电泳研究第四补体成分的转化。

Conversion of the fourth complement component studied by crossed immunoelectrophoresis.

作者信息

Sjöholm A G, Laurell A B

出版信息

Clin Exp Immunol. 1973 Aug;14(4):515-29.

PMID:4127020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1553814/
Abstract

C4 in EDTA plasma and partially purified C4 give a β peak on crossed immunoelectrophoresis. During electrophoresis C4 in serum is converted to a product of fast β mobility, usually accompanied by a slow β peak. Conversion in serum is inhibited by EDTA. Storage of serum at room temperature results in a gradual increase of the slow β peak. Storage of EDTA plasma changes the configuration of the native β peak. C[unk]s, trypsin, chymotrypsin, plasmin or thrombin added to partially purified C4 is capable of producing a fast β C4 protein peak. C[unk]s, trypsin and chymotrypsin give this conversion product also when added to EDTA serum. C[unk]s, trypsin and chymotrypsin also give rise to a show β and an inter α C4 conversion product in serum, probably consisting of complex formations between C4 and other serum proteins. Enzyme inhibitors known to interfere with C[unk] inhibit the conversion of C4 in serum on agarose electrophoresis. The results suggest that such conversion is caused by an activation of C1 during electrophoresis.

摘要

乙二胺四乙酸(EDTA)血浆中的C4和部分纯化的C4在交叉免疫电泳中呈现β峰。在电泳过程中,血清中的C4会转化为具有快速β迁移率的产物,通常伴有一个缓慢的β峰。血清中的这种转化受到EDTA的抑制。血清在室温下储存会导致缓慢β峰逐渐增加。EDTA血浆的储存会改变天然β峰的构型。添加到部分纯化的C4中的C[unk]s、胰蛋白酶、糜蛋白酶、纤溶酶或凝血酶能够产生快速β C4蛋白峰。当添加到EDTA血清中时,C[unk]s、胰蛋白酶和糜蛋白酶也会产生这种转化产物。C[unk]s、胰蛋白酶和糜蛋白酶在血清中还会产生一个缓慢的β峰和一个中间α C4转化产物,可能是由C4与其他血清蛋白之间的复合物形成所致。已知干扰C[unk]的酶抑制剂会抑制琼脂糖电泳中血清中C4的转化。结果表明,这种转化是由电泳过程中C1的激活引起的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/1553814/b589cb876f0e/clinexpimmunol00285-0054-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/1553814/bf07ca5cd4fb/clinexpimmunol00285-0047-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/1553814/df94b2bb1e33/clinexpimmunol00285-0048-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/1553814/93cb1cf2120d/clinexpimmunol00285-0050-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/1553814/fea6da896166/clinexpimmunol00285-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/1553814/b589cb876f0e/clinexpimmunol00285-0054-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/1553814/bf07ca5cd4fb/clinexpimmunol00285-0047-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/1553814/df94b2bb1e33/clinexpimmunol00285-0048-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/1553814/93cb1cf2120d/clinexpimmunol00285-0050-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/1553814/fea6da896166/clinexpimmunol00285-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/1553814/b589cb876f0e/clinexpimmunol00285-0054-a.jpg

相似文献

1
Conversion of the fourth complement component studied by crossed immunoelectrophoresis.通过交叉免疫电泳研究第四补体成分的转化。
Clin Exp Immunol. 1973 Aug;14(4):515-29.
2
An improved method for separation of the fourth component of complement and C4 inactivating substance.一种分离补体第四成分和C4灭活物质的改进方法。
Jpn J Exp Med. 1972 Oct;42(5):423-34.
3
Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.酵母聚糖上C3裂解备解素酶的形成。证明因子D可被蛋白水解酶替代。
J Immunol. 1974 Dec;113(6):1735-43.
4
Derivatives of the complement component MuB1 (C5mu) and separation of a factor involved in the conversion of MuB1 to MuB1f.补体成分MuB1(C5mu)的衍生物以及参与MuB1向MuB1f转化的一个因子的分离
Int Arch Allergy Appl Immunol. 1970;39(5-6):540-65. doi: 10.1159/000230381.
5
Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.C反应蛋白复合物与补体系统的相互作用。II. CRP复合物对豚鼠补体的消耗:对人C1q的需求
J Immunol. 1974 Jul;113(1):9-17.
6
Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.反应性溶解:补体介导的未致敏细胞溶解。I. 指示因子的特性及其鉴定为C7。
J Exp Med. 1970 Apr 1;131(4):629-41. doi: 10.1084/jem.131.4.629.
7
A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.一种使用EAC'la-gp和功能纯的人第二补体成分对正常人血清中补体第四成分进行的化学计量分析。
J Immunol. 1967 Dec;99(6):1162-72.
8
The activation of Cls with purified Clr.用纯化的Clr激活Cls。
Immunochemistry. 1974 Apr;11(4):191-6. doi: 10.1016/0019-2791(74)90327-9.
9
Purification of C 1S , a subunit of the first component of complement from human plasma.从人血浆中纯化补体第一成分的一个亚基C1S。
Biochim Biophys Acta. 1973 Jan 25;295(1):252-7. doi: 10.1016/0005-2795(73)90092-5.
10
Immunochemical quantitation of human Cl esterase (Cls): concentration in normal serum and purification yields.人C1酯酶(C1s)的免疫化学定量:正常血清中的浓度及纯化产率
J Immunol. 1970 Jul;105(1):170-4.

引用本文的文献

1
Effect of treatment with 17 alpha-alkylated androgens on C4 conversion products in hereditary angioedema studied by crossed immunoelectrophoresis.用交叉免疫电泳研究17α-烷基化雄激素治疗对遗传性血管性水肿中C4转化产物的影响。
J Clin Pathol. 1982 Jul;35(7):728-31. doi: 10.1136/jcp.35.7.728.
2
Clinical applications of immunofixation: detection and quantitation of complement activation.免疫固定法的临床应用:补体激活的检测与定量分析
J Clin Pathol. 1980 Aug;33(8):781-5. doi: 10.1136/jcp.33.8.781.
3
Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S.

本文引用的文献

1
The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide.加速素在人体血液凝固中的作用。关于加速素被活化的斯图尔特因子转化为凝血酶原转化因子的证据:兼论大豆胰蛋白酶抑制剂、硫酸鱼精蛋白和溴化己二甲铵的抗凝作用。
J Clin Invest. 1965 Feb;44(2):302-14. doi: 10.1172/JCI105144.
2
Assay and properties of serum inhibitor of C'l-esterase.C1酯酶血清抑制剂的测定与特性
Proc Soc Exp Biol Med. 1959 Aug-Sep;101:608-11. doi: 10.3181/00379727-101-25034.
3
人C4b结合蛋白的纯化及其与维生素K依赖性蛋白S复合物的形成。
Biochem J. 1983 Mar 1;209(3):847-56. doi: 10.1042/bj2090847.
4
Murine antigen H-2.7: localization of its antigenic determinant to the Ss (C4) molecule.小鼠抗原H-2.7:其抗原决定簇在Ss(C4)分子上的定位
Immunogenetics. 1980;11(6):605-15. doi: 10.1007/BF01567829.
5
Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.测量C4d以评估经典补体途径激活的新技术的临床应用。
J Clin Pathol. 1988 Feb;41(2):143-7. doi: 10.1136/jcp.41.2.143.
6
Activation of complement in relation to disease.补体激活与疾病的关系。
J Clin Pathol Suppl (Assoc Clin Pathol). 1975;6:38-44. doi: 10.1136/jcp.s1-6.1.38.
7
Structural and functional differences between the H-2 controlled Ss and Slp proteins.H-2 控制的 Ss 蛋白和 Slp 蛋白之间的结构与功能差异。
J Exp Med. 1978 Nov 1;148(5):1186-97. doi: 10.1084/jem.148.5.1186.
8
Human C4-binding protein. I. Isolation and characterization.人C4结合蛋白。I. 分离与特性鉴定。
J Exp Med. 1978 Jul 1;148(1):207-22. doi: 10.1084/jem.148.1.207.
9
Complement activity in middle ear effusions.
Clin Exp Immunol. 1978 Aug;33(2):340-6.
ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.
抗原-抗体交叉电泳
Anal Biochem. 1965 Feb;10:358-61. doi: 10.1016/0003-2697(65)90278-2.
4
THE INTERACTION BETWEEN CARRAGEENAN AND THE FIRST COMPONENT OF COMPLEMENT.角叉菜胶与补体第一成分之间的相互作用
J Immunol. 1965 May;94:662-6.
5
C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.C1酯酶对补体第四成分活性及理化性质的影响
J Exp Med. 1965 May 1;121(5):819-33. doi: 10.1084/jem.121.5.819.
6
INHIBITION OF THE C'-1 COMPONENT OF COMPLEMENT BY AMINO ACIDS.氨基酸对补体C'-1成分的抑制作用。
Immunology. 1964 Jul;7(4):319-31.
7
STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.人C1酯酶的研究。I. 纯化及酶学性质
J Immunol. 1964 Mar;92:456-67.
8
Chromatographic resolution of the first component of human complement into three activities.将人类补体的第一成分通过色谱法分离为三种活性。
J Exp Med. 1963 Jun 1;117(6):983-1008. doi: 10.1084/jem.117.6.983.
9
[Fibrin agar electrophoresis. 1. Description of the method].
Thromb Diath Haemorrh. 1962 Jul 15;7:432-43.
10
Preparation of complement reagents by means of gel filtration.通过凝胶过滤法制备补体试剂。
Acta Pathol Microbiol Scand. 1962;54:439-48.